Ansell Ltd
Company Profile
Business description
Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 55% of revenue and 50% of operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents, and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly across more than 100 countries. In fiscal 2025, Ansell earned 46% of revenue in North America, 31% from Europe, Middle East, and Africa, 14% across Asia-Pacific, and the remaining 10% in Latin America.
Contact
678 Victoria Street
Level 3
Richmond
MelbourneVIC3121
AUST: +61 392707222
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
30 June 2026
Employees
15,724
Stocks News & Analysis
stocks
Does SpaceX’s sky-high valuation make sense?
stocks
ASX healthcare leader sees further cuts to fair value
stocks
Avoid this overpriced ASX share
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,976.80 | 44.30 | 0.50% |
| CAC 40 | 8,041.81 | 126.45 | 1.60% |
| DAX 40 | 23,640.03 | 328.60 | -1.37% |
| Dow JONES (US) | 47,370.78 | 335.73 | -0.70% |
| FTSE 100 | 10,353.77 | 58.47 | -0.56% |
| HKSE | 25,898.76 | 490.30 | 1.93% |
| NASDAQ | 22,685.25 | 11.85 | -0.05% |
| Nikkei 225 | 55,025.37 | 776.98 | 1.43% |
| NZX 50 Index | 13,293.13 | 194.30 | 1.48% |
| S&P 500 | 6,767.40 | 14.08 | -0.21% |
| S&P/ASX 200 | 8,743.50 | 39.10 | 0.45% |
| SSE Composite Index | 4,133.43 | 10.29 | 0.25% |